Author: Vivian Xie 29th May 2026

The pharmaceutical industry is undergoing a period of unprecedented transformation. From rapid advancements in biologics and cell therapies to the integration of artificial intelligence in drug development, the pace of change has never been more intense. In this dynamic environment, staying ahead to industry trends, creating and maintaining partnerships, and accessing cutting-edge solutions is essential to thrive as part of both the marketplace and the pharma community as a whole.

Launching at Philadelphia’s Pennsylvania Convention Center on June 2, CPHI Americas 2026 is a three-day event which offers the pharmaceutical industry precisely what the moment demands: a premium, content-first experience specifically designed for the contract development and manufacturing ecosystem.

A Transforming Industry Needs a Reimagined Event

This year’s edition of CPHI Americas represents far more than an incremental improvement over previous years. Moving beyond the traditional trade show format, our upcoming show is driven by a specialized focus on contract manufacturing, ensuring every aspect of programming, networking, and content delivers maximum relevance and business value to the CDMO and CMO community. This evolution comes in direct response to the industry's shifting dynamics; the rise in outsourcing has created an ecosystem where CDMOs, CMOs, biotech innovators, regulatory experts, investors, private equity groups, and technology partners must collaborate more closely than ever before.

CPHI Americas 2026 positions itself at the center of this ecosystem, providing the platform where these critical relationships can be formed, strengthened, and leveraged for mutual success. With over 295 exhibitors, 3,700 attendees, and 80+ industry thought leaders confirmed for this year’s show, you’ll get unparalleled access to the decision-makers, innovators, and experts shaping the future of pharmaceutical manufacturing in the Americas.

Content That Tackles the Issues Keeping You Up at Night

One of CPHI Americas’ most distinctive features is its commitment to addressing the controversial, complex issues that pharmaceutical professionals genuinely grapple with, with three days of discussions which ask the difficult questions and demands actionable answers.

Featured content tracks include:

The CDMO Panel: Last year’s most popular lunch session returns, bringing together the biggest players in contract manufacturing for candid discussions about market dynamics, capacity constraints, technology investments, and partnership strategies. Forget corporate polish and sugarcoating, this is real talk from industry leaders about the challenges and opportunities shaping the CDMO landscape.

Government & Regulatory Insights Track: In an environment where regulatory shifts can derail development timelines and impact market access, direct access to regulatory thinking provides invaluable strategic intelligence. This track showcases experts from the FDA and other regulatory authorities, this track addresses the daily changes in compliance requirements, onshoring incentives and requirements, AI oversight and validation, and evolving quality standards.

The Hot Seat: These high-energy, moderated panels tackle controversial industry issues head-on, from onshoring incentives and their practical implications to pricing transparency debates and global supply chain dependence. The format encourages frank discussion and diverse perspectives, moving beyond consensus positions to explore the tensions and trade-offs that characterize real-world decision-making.

The speaker lineup reflects this commitment to substantive content. Over 80 industry thought leaders, including voices from the FDA, will share insights, challenge assumptions, and facilitate discussions that advance industry thinking. Notable speakers include Richard Pazdur, Sirsij Peshin, Mike Martin, Molly Klote, Mayank Nagar, Derek Booth, Nishtha Jain, Luiz Barberini, Daniel Cohen, and John Nosta, founder of NOSTALAB and author of The Borrowed Mind, who will conduct a book signing on June 3, 2026.

Networking That Drives Business Results

While our content provides intellectual value, it’s the opportunities for networking where CPHI Americas delivers business results. We understand that this is many people’s primary reason for attending industry events, so we’re dedicated to putting that at the heart of our show.

The exhibition floor brings together leading pharmaceutical companies and solution providers, including Pfizer CentreOne, Olon, Pyramic Labs, Euro API, Actylis, and Curia, alongside innovative startups and specialized service providers. This diversity ensures attendees can explore established partnerships whilst discovering emerging capabilities that might help them fill gaps in their services, or even the wider pharma marketplace as a whole.

Beyond traditional booth interactions, CPHI Americas 2026 will also feature the Game On! Play and Connect Hub, a high-energy networking area that fuses connection with fun in a sports-inspired environment. This innovative space recognizes that meaningful relationships are best formed in relaxed, engaging settings, so by creating an environment that encourages authentic interaction, the hub will facilitate the personal connections that underpin successful business partnerships.

The event's digital infrastructure further enhances networking efficiency. CPHI’s online platform and event app enable attendees to browse exhibitor and speaker profiles, review session schedules, and connect directly with potential partners before, during, and after the event. This digital layer gives attendees the opportunity to make the most of the time they have during the event, focusing face-to-face interactions on high-priority connections whilst maintaining their broader network development through digital channels.

Insights That Extend Beyond the Event

CPHI Americas' value extends well beyond the three June days it spans. The event's comprehensive Insights Hub offers year-round access to industry intelligence, expert analysis, and thought leadership that keeps pharmaceutical professionals informed about emerging trends and evolving best practices.

Recent content available through the Insights Hub addresses critical topics including:

• optimizing costs in US biopharma development 
• pharma packaging for global markets 
• the future of contract packaging in the US pharma industry 
• integrated pharma and regulatory compliance 
• how CDMOs are revolutionizing biologics 
• production sustainability in US biopharma 
• operations and many more significant issues

This content library ensures that the learning and insights gained at CPHI Americas continue delivering value long after the event concludes, whilst also providing context and preparation for attendees planning their conference experience.

CPHI: A Legacy Built on Exceptional Experiences

CPHI Americas' track record demonstrates its value to the pharmaceutical community. The 2025 event attracted 3,700 attendees, featured 295+ exhibitors, showcased 16 startups, delivered 55 content sessions, and brought together 86 speakers. Attendee testimonials confirm the event's business impact:

Dan from Cambrex noted: 

"For us, CPHI Americas is about meeting our clients in a single location, and giving us the venue to do all of this in a concentrated time frame."

Martin from Kraftpal observed: 

"We feel it's a great trade event to get in front of the key decision makers, who can help us make decisions for our future technologies, we hope to participate again."

These testimonials highlight CPHI Americas' core value proposition: efficiency. In an industry where decision-makers' time is increasingly constrained, the ability to conduct multiple high-value meetings, attend relevant educational sessions, and explore new solutions within a concentrated three-day period represents substantial return on investment.

This year’s edition builds on that foundation whilst introducing enhancements that respond to attendee feedback and industry evolution. The premium, content-first approach ensures that every element from speaker selection to networking formats to exhibition curation delivers maximum relevance and ROI for the contract manufacturing ecosystem.

The Time Is Now

Regulatory landscapes are shifting. Technology capabilities are advancing. Supply chain strategies are being reconsidered. Sustainability expectations are intensifying. Partnership models are evolving. In this environment, those who remain isolated risk falling behind competitors who leverage collective industry intelligence and collaborative partnerships. The companies and professionals who stay connected to industry developments are the ones who will thrive.

CPHI Americas 2026 provides the platform where pharmaceutical professionals can position themselves and their organizations for success in this dynamic environment. Whether you're seeking CDMO partnerships to support pipeline advancement, exploring technologies to improve manufacturing efficiency, navigating regulatory complexities, or building relationships with potential collaborators and customers, this is an event which delivers concentrated access to the people, insights, and solutions that matter most.

The future of pharma is being manufactured at CPHI Americas. Will you be there to shape it?

For more information and to register, visit: https://www.cphi.com/americas/